Aktionsplan Profound Medical Corp.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. weitere details| IPO date | 2016-06-09 |
|---|---|
| ISIN | CA74319B5027 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.profoundmedical.com |
| Цена ао | 8.15 |
| Preisänderung pro Tag: | +1.42% (7.05) |
|---|---|
| Preisänderung pro Woche: | -1.38% (7.25) |
| Preisänderung pro Monat: | -12.27% (8.15) |
| Preisänderung über 3 Monate: | -9.72% (7.92) |
| Preisänderung über sechs Monate: | -16.67% (8.58) |
| Preisänderung pro Jahr: | -15.78% (8.49) |
| Preisänderung über 3 Jahre: | -33.12% (10.69) |
| Preisänderung über 5 Jahre: | -14.43% (8.3556) |
| Preisänderung über 10 Jahre: | 0% (7.15) |
| Preisänderung seit Jahresbeginn: | -12.27% (8.15) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| Gagnon Securities, LLC | 1541576 | 6.31 |
| FIL LTD | 1200635 | 4.91 |
| Letko, Brosseau & Associates Inc. | 1177850 | 4.82 |
| Gagnon Advisors, LLC | 679296 | 2.78 |
| AIGH Capital Management LLC | 646733 | 2.65 |
| Raymond James Financial Services Advisors, Inc. | 622552 | 2.55 |
| Timelo Investment Management Inc. | 611758 | 2.5 |
| Royce & Associates LP | 564298 | 2.31 |
| Rosalind Advisors, Inc. | 533333 | 2.18 |
| Royal Bank of Canada | 400159 | 1.64 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman of the Board & CEO | 435.87k | 1955 (70 Jahre) |
| Mr. Rashed Dewan | Chief Financial Officer | 215.18k | 1968 (57 Jahre) |
| Mr. Hartmut Warnken | Senior Vice President for Strategic Alliances | 226.17k | 1973 (52 Jahr) |
| Dr. Mathieu Burtnyk | Chief Operating Officer | 215.18k | 1982 (43 Jahr) |
| Mr. Stephen Kilmer | Investor Relations | N/A | |
| Mr. Jacques F. Cornet | VP of International Sales & Marketing | N/A | 1956 (69 Jahre) |
| Mr. Matthew Sobczyk C.A., CPA | Assistant Corporate Controller | N/A | |
| Mr. Levant Tinaz | Software Developer | N/A | |
| Ms. Abbey Goodman | Chief Commercial Officer of Global | 1983 (42 Jahr) |
Adresse: Canada, Mississauga. ON LW K, 2400 Skymark Avenue - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.profoundmedical.com
Webseite: https://www.profoundmedical.com
